vs
Apellis Pharmaceuticals, Inc.（APLS）与BOX INC（BOX）财务数据对比。点击上方公司名可切换其他公司
BOX INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.5倍（$301.1M vs $199.9M），BOX INC净利率更高（4.0% vs -29.5%，领先33.5%），BOX INC同比增速更快（9.1% vs -5.9%），BOX INC自由现金流更多（$71.3M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 7.0%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Box Inc.是总部位于美国加利福尼亚州红木城的上市企业，由亚伦·莱维和迪伦·史密斯于2005年创立，最初面向个人消费者服务，2009至2010年前后转向企业级市场，2015年正式上市。公司专注于开发、运营云端内容管理、协同办公及文件共享工具，帮助企业用户便捷存储、管理各类文件，提升团队协作效率。
APLS vs BOX — 直观对比
营收规模更大
BOX
是对方的1.5倍
$199.9M
营收增速更快
BOX
高出15.1%
-5.9%
净利率更高
BOX
高出33.5%
-29.5%
自由现金流更多
BOX
多$85.6M
$-14.3M
两年增速更快
APLS
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $301.1M |
| 净利润 | $-59.0M | $12.1M |
| 毛利率 | — | 79.6% |
| 营业利润率 | -25.6% | 8.3% |
| 净利率 | -29.5% | 4.0% |
| 营收同比 | -5.9% | 9.1% |
| 净利润同比 | -62.2% | -6.4% |
| 每股收益（稀释后） | $-0.40 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSBOX
| Q4 25 | $199.9M | $301.1M | ||
| Q3 25 | $458.6M | $294.0M | ||
| Q2 25 | $178.5M | $276.3M | ||
| Q1 25 | $166.8M | $279.5M | ||
| Q4 24 | $212.5M | $275.9M | ||
| Q3 24 | $196.8M | $270.0M | ||
| Q2 24 | $199.7M | $264.7M | ||
| Q1 24 | $172.3M | $262.9M |
净利润APLSBOX
| Q4 25 | $-59.0M | $12.1M | ||
| Q3 25 | $215.7M | $13.4M | ||
| Q2 25 | $-42.2M | $8.2M | ||
| Q1 25 | $-92.2M | $194.0M | ||
| Q4 24 | $-36.4M | $12.9M | ||
| Q3 24 | $-57.4M | $20.5M | ||
| Q2 24 | $-37.7M | $17.2M | ||
| Q1 24 | $-66.4M | $99.2M |
毛利率APLSBOX
| Q4 25 | — | 79.6% | ||
| Q3 25 | — | 79.1% | ||
| Q2 25 | — | 78.0% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 79.9% | ||
| Q3 24 | — | 79.4% | ||
| Q2 24 | — | 78.0% | ||
| Q1 24 | — | 76.1% |
营业利润率APLSBOX
| Q4 25 | -25.6% | 8.3% | ||
| Q3 25 | 48.7% | 7.0% | ||
| Q2 25 | -18.6% | 2.3% | ||
| Q1 25 | -50.0% | 6.4% | ||
| Q4 24 | -12.3% | 8.5% | ||
| Q3 24 | -24.0% | 7.5% | ||
| Q2 24 | -14.7% | 6.8% | ||
| Q1 24 | -36.0% | 8.1% |
净利率APLSBOX
| Q4 25 | -29.5% | 4.0% | ||
| Q3 25 | 47.0% | 4.6% | ||
| Q2 25 | -23.6% | 3.0% | ||
| Q1 25 | -55.3% | 69.4% | ||
| Q4 24 | -17.1% | 4.7% | ||
| Q3 24 | -29.2% | 7.6% | ||
| Q2 24 | -18.9% | 6.5% | ||
| Q1 24 | -38.5% | 37.7% |
每股收益（稀释后）APLSBOX
| Q4 25 | $-0.40 | $0.05 | ||
| Q3 25 | $1.67 | $0.05 | ||
| Q2 25 | $-0.33 | $0.02 | ||
| Q1 25 | $-0.74 | $1.13 | ||
| Q4 24 | $-0.30 | $0.05 | ||
| Q3 24 | $-0.46 | $0.10 | ||
| Q2 24 | $-0.30 | $0.08 | ||
| Q1 24 | $-0.54 | $0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $729.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $-286.6M |
| 总资产 | $1.1B | $1.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSBOX
| Q4 25 | $466.2M | $729.6M | ||
| Q3 25 | $479.2M | $757.9M | ||
| Q2 25 | $370.0M | $790.4M | ||
| Q1 25 | $358.4M | $722.8M | ||
| Q4 24 | $411.3M | $697.9M | ||
| Q3 24 | $396.9M | $482.2M | ||
| Q2 24 | $360.1M | $566.1M | ||
| Q1 24 | $325.9M | $480.7M |
总债务APLSBOX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSBOX
| Q4 25 | $370.1M | $-286.6M | ||
| Q3 25 | $401.2M | $-269.4M | ||
| Q2 25 | $156.3M | $-280.1M | ||
| Q1 25 | $164.2M | $-297.0M | ||
| Q4 24 | $228.5M | $-479.9M | ||
| Q3 24 | $237.1M | $-439.4M | ||
| Q2 24 | $264.3M | $-397.9M | ||
| Q1 24 | $266.7M | $-431.1M |
总资产APLSBOX
| Q4 25 | $1.1B | $1.6B | ||
| Q3 25 | $1.1B | $1.6B | ||
| Q2 25 | $821.4M | $1.6B | ||
| Q1 25 | $807.3M | $1.7B | ||
| Q4 24 | $885.1M | $1.4B | ||
| Q3 24 | $901.9M | $1.1B | ||
| Q2 24 | $904.5M | $1.2B | ||
| Q1 24 | $831.9M | $1.2B |
负债/权益比APLSBOX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $73.0M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $71.3M |
| 自由现金流率自由现金流/营收 | -7.1% | 23.7% |
| 资本支出强度资本支出/营收 | 0.1% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 6.05× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $343.5M |
8季度趋势，按日历期对齐
经营现金流APLSBOX
| Q4 25 | $-14.2M | $73.0M | ||
| Q3 25 | $108.5M | $46.0M | ||
| Q2 25 | $4.4M | $127.1M | ||
| Q1 25 | $-53.4M | $102.2M | ||
| Q4 24 | $19.4M | $62.6M | ||
| Q3 24 | $34.1M | $36.3M | ||
| Q2 24 | $-8.3M | $131.2M | ||
| Q1 24 | $-133.0M | $89.3M |
自由现金流APLSBOX
| Q4 25 | $-14.3M | $71.3M | ||
| Q3 25 | $108.3M | $43.9M | ||
| Q2 25 | $4.4M | $126.7M | ||
| Q1 25 | $-53.4M | $101.5M | ||
| Q4 24 | $19.3M | $62.3M | ||
| Q3 24 | — | $35.9M | ||
| Q2 24 | $-8.4M | $129.9M | ||
| Q1 24 | $-133.3M | $89.1M |
自由现金流率APLSBOX
| Q4 25 | -7.1% | 23.7% | ||
| Q3 25 | 23.6% | 14.9% | ||
| Q2 25 | 2.5% | 45.9% | ||
| Q1 25 | -32.0% | 36.3% | ||
| Q4 24 | 9.1% | 22.6% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | -4.2% | 49.1% | ||
| Q1 24 | -77.3% | 33.9% |
资本支出强度APLSBOX
| Q4 25 | 0.1% | 0.6% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.0% | 0.5% | ||
| Q1 24 | 0.2% | 0.1% |
现金转化率APLSBOX
| Q4 25 | — | 6.05× | ||
| Q3 25 | 0.50× | 3.42× | ||
| Q2 25 | — | 15.51× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 4.85× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 7.62× | ||
| Q1 24 | — | 0.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
BOX
暂无分部数据
